/PRNewswire/ Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from the second of three Phase 3 clinical studies.
Call to Action: The Rise for Architecture Report canadianarchitect.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from canadianarchitect.com Daily Mail and Mail on Sunday newspapers.